DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023" drug pipelines to their offering.
The therapeutic market size for Cervical Cancer will increase at a Compound Annual Growth Rate of 1.39% and will reach up to USD 231.93 million globally in 2023. The global market size for prophylaxis treatment of Cervical Cancer is expected to grow at a CAGR of 0.71% and reach up to USD 2210.9 Million by 2023.
Global Cervical Cancer Market Insights, Epidemiology and Market Forecast 2023 provides an overview of the disease and global market size of the Cervical Cancer for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Cervical Cancer from 2013-2023.
Cervical Cancer needs to be focused more and more because it adversely affects younger women. It is the fourth most common cause of death among women. Cervical Cancer occurs due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus.
Key Topics Covered:
- Cervical Cancer Disease Overview
- Epidemiology and Patient Population of Cervical Cancer
- United States
- United Kingdom (UK)
- Germany (GE)
- Italy (IT)
- France (FR)
- Spain (SP)
- Japan (JP)
- Treatment Landscape
- Treatment Algorithm
- Treatment by Stages
- Cervical Cancer Treatment Regimens
- Current Unmet Needs
- Cervical Cancer Therapeutic Treatments
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/tdr2mv/cervical